AlphaOmegaEnergy, the world's leading breakthrough clean energy tech startup, is thrilled to announce a significant funding milestone, having raised $5,000 in their latest financial round. Founded in 2015 and recognized as a pioneering force in sustainable technology, AlphaOmegaEnergy boasts an impressive portfolio of over 4,682 innovative energy solutions, including the world鈥檚 #1 fuel cell and cutting-edge electric plane designs capable of flying over 2,800 kilometers. This recent funding will be pivotal in helping the company continue its mission of delivering advanced clean energy technologies and addressing critical global energy challenges. With awards ranging from Cambodia's national startup competition to international accolades, AlphaOmegaEnergy is well positioned to capitalize on the $13 billion per year demand backorder and the growing interest in sustainable energy solutions. As a pre-seed startup, AOE has yet to receive commercialization-level funding, making this an attractive opportunity for emerging managers and venture capital funds looking to anchor their investments. The company鈥檚 strategic focus on diverse areas such as hydroelectric technology, energy efficiency, and oceanic power solutions, along with robust demand, sets the stage for exponential growth. AlphaOmegaEnergy aims to leverage this funding to further develop groundbreaking tech solutions, expand its market reach, and contribute significantly to global sustainability efforts. With such a strong foundation and an unwavering commitment to innovation, AlphaOmegaEnergy continues to emerge as a game-changer in the clean energy landscape.
AlphaOmegaEnergy Secures $500k in Pre-Seed Funding for Revolutionary Clean Energy Tech Innovations
Recently funded 路 $5.0K Pre-seedSecurity
Get the full AlphaOmegaEnergy company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Xentra
From cyber security, through to safeguarding and compliance, we provide digital security solutions perfectly designed to suit any requirement. Our team of experts will help you assess, select and implement the right solutions for your organisation; setting you up for success and helping you deliver against key objectives. We pride ourselves on understanding the digital security landscape, thoroughly evaluating available technologies and building long-term partnerships with our customers. We don鈥檛 believe in quick fixes. Whether you require a point solution to tackle a single requirement, or would benefit from a complete managed service, our solutions are built to stand the test of time. Since 2020, we鈥檝e been helping organisations such as Leeds United Football Club, Thomas鈥檚 London Day Schools, Setfords, JT Atkinson and Northern Estate Agencies Group, manage and optimise their overall digital security. Along the way, we have set the standard for what a customer-first approach to digital security looks like, and how to measure success.
$3.5M Series a
today
Estrigenix Therapeutics, Inc.
Estrigenix Therapeutics, Inc. is a privately held pharmaceutical company developing the next generation of innovative therapies for improving the mental health of menopausal women. Menopause is associated with cognitive dysfunction, increased mood and anxiety disorders, and an elevated risk of Alzheimer鈥檚 disease, yet standard estrogen therapies are associated with increased risks of cancer, heart disease, and stroke. Our mission is to develop novel drugs that mitigate the adverse effects of menopause on mental health and enable women to live healthier and happier lives. The drug development program at Estrigenix focuses on selectively activating specific estrogen receptor proteins that promote memory formation, improve mood, and reduce anxiety. We believe that targeting these receptors will provide the cognitive and mood-enhancing benefits of estrogens without the harmful side effects of standard estrogen therapies. Our lead compound, EGX-358, is a potent and selective agonist of the estrogen receptor beta protein, which enhances memory formation in a mouse model of menopause. Current work is expanding the use of this compound to other indications, including depression, anxiety, and hot flashes.
Other recent Pre-seed rounds
Companies that recently closed a Pre-seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  FLOWT United States | Pre-seed | $1.0M | today |
| 2 |  Aerion Motors Indonesia | Pre-seed | $600.0K | today |
| 3 |
